Metabolism-dependent inhibition of CYP3A4 and CYP2D6 by extracts from 26 herbal medicines

Journal of Traditional Medicines

Volumn 21, Issue 6, 2004, Pages 281-286

  Iwata, Hiroshi ^a,b   Tezuka, Yasuhiro ^a   Kadota, Shigetoshi ^a   Hiratsuka, Akira ^c   Watabe, Tadashi ^d  

^a UNIVERSITY OF TOYAMA   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

CYP2D6; CYP3A4; herb; human liver microsomes; inhibition

Indexed keywords

EID: 85009569575     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.21.281     Document Type: Article

References (13)

1. Madan, A., Usuki, E., Burton, L.A., Ogilvie, B.W., and Parkinson, A.: In vitro approaches for studying the inhibition of drug-metabolizing enzymes and identifying the drug-metabolizing enzymes responsible for the metabolism of drugs. “In Drug-Drug Interactions” (Ed. by Rodrigues, A.D.), Marcel Dekker, New York, pp. 217-294, 2002.
2. Okuda, H., Ogura, K., Kato, A., Takubo, H. and Watabe, T.: A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. J. Pharmacol. Exp. Ther., 287, 791-799, 1999.
3. Periti, P., Mazzei, T., Mini, E. and Novelli, A.: Pharmacokinetic drug interactions of macrolides. Clin. Pharmacokinet., 23, 106-131, 1992.
4. Kunze, K.L. and Trager, W.F.: Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem. Res. Toxicol., 6, 649-656, 1993.
5. Murray, M. and Reidy, G.F.: Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev., 42, 85-101, 1990.
6. Iwata, H., Tezuka, Y., Usia, T., Kadota, S., Hiratsuka, A. and Watabe, T.: Inhibition of human liver microsomal CYP3A4 and CYP2D6 by extracts from 78 herbal medicines. J. Trad. Med., 21, 42-50, 2004.
7. Bertelsen, K.M., Venkatakrishnan, K., Moltke, L.L.V., Obach, R.S. and Greenblatt, D.J.: Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine. Drug. Metab. Dispos., 31, 289-293, 2003.
8. Bailey, D.G., Arnold, M. and Spence, D.: Grapefruit juice-drug interactions. Br. J. Clin. Pharmacol., 46, 101-110, 1998.
9. Tassaneeyakul, W., Guo, L.Q., Fukuda, K., Ohta, T. and Yamazoe, Y.: Inhibition selectivity of grapefruit juice components on human cytochrome P450. Arch. Biochem.Biophys., 378, 356-363, 2000.
10. Guo, L.Q., Taniguchi, M., Xiao, Y-Q., Baba, K., Ohta, T. and Yamazoe, Y.: Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn. J. Pharmacol., 82, 122-129, 2000.
11. Kent, U.M., Aviram, M., Rosenblat, M. and Hollenberg, P.F.: The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. Drug. Metab. Dispos., 30, 709-715, 2002.
12. Ohyama, K., Nakajima, M., Suzuki, M., Shimada, N., Yamazaki, H. and Yokoi, T.: Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Br. J. Clin. Pharmacol., 49, 244-253, 2000.
13. Sutton, D., Butler, A.M., Nadin, L. and Murray, M.: Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J. Pharmacol. Exp. Ther., 282, 294-300, 1997.